Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

Background: Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are currently no approved pharmac...

Full description

Bibliographic Details
Main Authors: Thomas RE Barnes, Verity C Leeson, Carol Paton, Céire Costelloe, Judit Simon, Noemi Kiss, David Osborn, Helen Killaspy, Tom KJ Craig, Shôn Lewis, Patrick Keown, Shajahan Ismail, Mike Crawford, David Baldwin, Glyn Lewis, John Geddes, Manoj Kumar, Rudresh Pathak, Simon Taylor
Format: Article
Language:English
Published: NIHR Journals Library 2016-04-01
Series:Health Technology Assessment
Subjects:
citalopram
antipsychotic
schizophrenia
negative symptoms
randomised controlled trial
ssri antidepressant
antipsychotic augmentation
Online Access:https://doi.org/10.3310/hta20290

Internet

https://doi.org/10.3310/hta20290

Similar Items